Results 161 to 170 of about 87,717 (260)

Importance of Hypercortisolism in BP Control, Cardiovascular Risk and in Patients With Difficult‐to‐Control Hypertension: An Overview for Primary Care Physicians

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Hypertension remains one of the most prevalent and consequential modifiable cardiovascular risk factors worldwide, affecting approximately 1.28 billion adults globally and nearly half of the United States population. Despite the availability of effective therapies, optimal blood pressure control is achieved in fewer than one in four ...
Matthew A. Cavender
wiley   +1 more source

Association among blood pressure, antihypertensive drugs, and amyotrophic lateral sclerosis. [PDF]

Arq Neuropsiquiatr
Li Z, Li Y, Zhao J, Zhang F, Dang W, Jia Y, Guo F, Guo L.   +7 more
europepmc   +1 more source

Hypercortisolism: Causes, Consequences and Clinical Significance – A Review of Pathophysiology

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Hypercortisolism or Cushing syndrome is a heterogeneous clinical spectrum caused by chronic glucocorticoid excess, ranging from exogenous Cushing syndrome to rare endogenous aetiologies and the increasingly recognised entity of mild autonomous cortisol secretion (MACS). Physiological cortisol production is tightly regulated by the hypothalamic–
Mohamed Eldib, Francisco Emilio Fierro, Maria Ortega Abad, Ricardo Correa   +3 more
wiley   +1 more source

Five-year follow-up with the incidence of cardiovascular adverse events after prescribing single-pill combination of antihypertensive drugs: retrospective cohort study. [PDF]

J Pharm Health Care Sci
Matsumura M, Nakamura T, Kadoyama K, Yano R, Iwanaga K, Imanishi K, Yamanishi K, Nakakura I, Une Y, Nakamura T.   +9 more
europepmc   +1 more source

How Common Is Hypercortisolism in Patients With Hypertension? Risk Factors, Epidemiology, and Making a Diagnosis

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Endogenous hypercortisolism (EHC) is an underrecognised and clinically significant contributor to hypertension, particularly resistant hypertension. Once viewed as a rare entity, EHC is now understood as a spectrum of cortisol excess associated with adverse cardiometabolic outcomes and target‐organ damage.
Omar Al Dhaybi, Deepak L. Bhatt
wiley   +1 more source

A Study of the Prescription Patterns of Antihypertensive Drugs in Patients Attending the Outpatient Department of Medicine at a Tertiary Care Hospital. [PDF]

Cureus
Shankpal PD, Lohi SM, Karande S, Bonde VN.   +3 more
europepmc   +1 more source

Antihypertensive drugs utilisation and educational activities

Open Medicine, 2010
Velickovic-Radovanovic Radmila, Petrovic Jasmina, Kodela Biljana, Janković Slobodan   +3 more
doaj   +1 more source

Systematic review of Mendelian randomization studies on antihypertensive drugs. [PDF]

BMC Med
Fan B, Zhang J, Zhao JV.
europepmc   +1 more source

Real‐World Effectiveness and Safety of Tirzepatide in Type 1 Diabetes and Obesity: Impact on Glycaemia, Weight, and Cardiometabolic Risk Markers

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To evaluate the effectiveness and safety of tirzepatide on glycaemia, weight, and markers of cardiometabolic risk in people with type 1 diabetes and obesity. Materials and Methods This retrospective cohort study compared 142 adults with type 1 diabetes (BMI ≥ 30 kg/m2) initiated on tirzepatide against 50 age‐, sex‐ and BMI‐matched ...
Simon A. Berry, Iona R. Goodman, Eleanor McNally, Jackie Elliott, Ahmed Iqbal   +4 more
wiley   +1 more source

Effect of antihypertensive drugs on survival in patients with non-small cell lung cancer on epidermal growth factor receptor inhibitors. [PDF]

Am J Cancer Res
Hsieh HH, Wu TY, Lee WY, Chen CH, Kuo YH, Lee HZ, Hour MJ.   +6 more
europepmc   +1 more source